Background and purpose Diabetic nephropathy (DN) is a common complication of diabetes. Current treatments include renin‐angiotensin‐aldosterone system (RAAS) blockers and sodium‐glucose co‐transporter 2 (SGLT2) inhibitors. The cannabinoid CB1 receptor is a potential therapeutic target.
Océane Pointeau +20 more
wiley +1 more source
A Simple Experimental Approach to Understanding the Formation of Advanced Glycation End Products. [PDF]
Miyazaki K, Miyazaki K, Kaseda K.
europepmc +1 more source
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts [PDF]
Heinz Fehrenbach +3 more
openalex +1 more source
The Role of Micronutrients in Atherosclerosis: Mechanisms and Clinical Application
ABSTRACT Micronutrients, though required in relatively small quantities by the human body, are essential for maintaining normal physiological functions and play a crucial role in the prevention and management of various diseases. Atherosclerosis (AS) is a common chronic inflammatory condition that often presents without obvious symptoms in its early ...
Yuxin Ouyang +5 more
wiley +1 more source
Non-invasive evaluation of advanced glycation end products in hair as early markers of diabetes and aging. [PDF]
Kato S, Satoh Y, Okamoto A, Nagai R.
europepmc +1 more source
Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells [PDF]
Karel Otero +7 more
openalex +1 more source
ABSTRACT To investigate the potential bidirectional causal relationship between specific blood metabolites and chronic periodontitis using Mendelian randomisation (MR). A two‐sample bidirectional MR analysis was conducted. Data on 1400 blood metabolites were obtained from a genome‐wide association study involving 8299 participants.
Weilun Cai +8 more
wiley +1 more source
Effects of melatonin on advanced glycation end products, inflammation, and oxidative stress in peritoneal dialysis patients: a randomized controlled trial. [PDF]
Movahedian M +6 more
europepmc +1 more source
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker [PDF]
David A. Kass +6 more
openalex +1 more source

